Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 24, 2013
Reporting Period: Fourth quarter and full year ended December 31, 2012
This filing serves as a notification that the Company issued a press release announcing its financial results for the fourth quarter and twelve months of 2012. The detailed financial data is contained in the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) incorporated by reference, rather than within the body of this 8-K form.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release and supplemental website information.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms the issuance of results for the 2012 period.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These elements are presumed to be detailed in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific 2012 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 for supplemental data regarding product sales, R&D pipeline updates, or segment performance.
- Verify the Company's forward-looking guidance and 2013 outlook provided in the press release.
- Check for any disclosed risks or contingencies related to the 2012 results in the referenced exhibits.